USSTOCK.TODAY
After-Market
Log in Sign up

Ionis Pharmaceuticals beats expectations with $243 million in Q3 revenue

Associated Press +1 · ·by G4L

IONS
IONS Ionis Pharmaceuticals Inc
$31.00 -21.36%
View chart & analysis →
  1. 1Ionis Pharmaceuticals recorded $243 million in revenue during the period.
  2. 2Ionis Pharmaceuticals reported a loss of $110 million in the third quarter.
  3. 3Ionis Pharmaceuticals recorded a loss of 66 cents per share in the third quarter.

So what's the key point?

Ionis Pharmaceuticals' third-quarter revenue of $243 million was higher than what experts expected. However, the company still recorded a loss of $110 million.

Source Associated Press +1 · View original ↗

Related 3-line summaries

Nvidia CEO Jensen Huang Faces Spy Allegations and Leadership Crisis Zero Hedge +20 · yesterdayAlnylam and Ionis: Comparing Investment Appeal in Biotech Amidst Adverse News The Motley Fool +1 · Oct 10Biogen Q2 Revenue and Adjusted EPS Beat Expectations, Guidance Raised InvestorsHub +13 · Jul 29
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news